Thyrocare Technologies Ltd.

NSE: THYROCARE | BSE: 539871 | ISIN: INE594H01019 | Industry: Healthcare Services
| Expensive Star
468.6500 16.05 (3.55%)
NSE Jan 13, 2026 15:31 PM
Volume: 377.6K
 

468.65
3.55%
Prabhudas Lilladhar
and 3) increased employee cost at 16% of sales (v/s 11% YoY and 13% QoQ). EBIT margin for diagnostic segment was 9% v/s 42% YoY. its profitability because of 1) lower gross margin at 53% (v/s 72% YoY) due to We remain negative on entire diagnostic chain due to possible structural...
Number of FII/FPI investors increased from 99 to 123 in Sep 2025 qtr.
More from Thyrocare Technologies Ltd.
Recommended